Abits Group Inc - Ordinary Shares (ABTS)
0.4233
-0.6267 (-59.69%)
NASDAQ · Last Trade: Nov 3rd, 2:07 PM EST
Abits Group Announces AI Infrastructure and High-Performance Computing Expansion Strategy
Company to evaluate existing U.S. power infrastructure and data center operations for potential AI infrastructure hosting opportunities
By Abits Group Inc. · Via ACCESS Newswire · November 3, 2026
IGC Pharma’s (NYSE: IGC) CEO Appears on Bloomberg TV Discussing Alzheimer’s Fast-Acting IGC-AD1 Pharmaceutical Therapeutic – More Stocks Inside
IGC Pharma, Inc. (NYSE: IGC), a clinical-stage AI biotechnology company focused on Alzheimer’s disease, is gaining investor attention after CEO Ram Mukunda appeared on Bloomberg TV discussing the company’s lead drug candidate, IGC-AD1, a potential fast-acting therapy for agitation associated with Alzheimer’s dementia .
Via AB Newswire · June 1, 2026